|Have Questions?||Leave a Message or Start an on-line Chat|
The production of the recombinant monoclonal antibody targeting GFAP involves the initial step of constructing GFAP antibody genes within plasmid vectors. These engineered plasmid vectors are subsequently introduced into appropriate host cells for expression using exogenous protein expression techniques. Following this, this GFAP recombinant monoclonal antibody goes through purification using affinity chromatography. It has been rigorously validated for various applications, including ELISA, WB, IHC, IF, and FC. This antibody exhibits reactivity with GFAP proteins derived from human, mouse, and rat species.
GFAP is a critical protein in astrocytes that provides structural support, participates in astrocyte activation and reactive gliosis, contributes to the blood-brain barrier's integrity, and has both neuroprotective and diagnostic roles in various neurological conditions.
There are currently no reviews for this product.